CORRECTION: AstraZeneca said that its antibody therapy met the main goal of preventing COVID-19 in a late-stage study, putting the British drugmaker on track to potentially offer an alternative to vaccines We will delete an earlier tweet without a video
But AstraZeneca is first to publish positive prevention trial data in the field and is now targeting conditional approval in major markets well before the end of the year, aiming to produce roughly 1 to 2 million doses by then.
"We’re really trying to help patients that need an added level of protection on top of a vaccine," said Pangalos. Concerns over the new Delta variant of COVID-19 and waning vaccine efficacy have prompted several high-income countries to offer a third vaccine shot on top of the usual two-shot regimen to the immunocompromised and other groups at risk.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
AstraZeneca Antibody Drug Found to Prevent Symptomatic Covid-19 in TrialThe company said it would seek regulatory approval after a study showed strong efficacy in preventing symptomatic Covid-19, offering a potential alternative to vaccines for people who refuse shots or for whom they aren’t effective.
Consulte Mais informação »
AstraZeneca says prospect of COVID-19 drug success underscores value of vaccine opsAn AstraZeneca executive said the prospect of offering a new treatment to prevent COVID-19 could position the British drugmaker as a supplier of both vaccines and drugs which guard against the infectious disease.
Consulte Mais informação »
Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.
Consulte Mais informação »
AstraZeneca’s Covid-19 Antibody Therapy Effective In Preventing Symptoms Among High-Risk Groups, Trial FindsAstraZeneca’s treatment may offer additional protection to vulnerable groups who fail to generate a strong immune response through vaccines.
Consulte Mais informação »
Pfizer’s Covid-19 Booster Shot Improves Immunity, Israeli Study SuggestsEarly data from Israel suggests a booster shot of Pfizer's Covid-19 vaccine can significantly improve immunity in those aged 60 and above, as other countries plan additional doses to increase protection against the highly infectious Delta variant
Consulte Mais informação »